€121.70
Your prediction
Agilent Technologies Inc. Stock
Agilent Technologies is a leading global manufacturer of measuring instruments, software, services, and solutions for chemical analysis, life sciences, diagnostics, and electronic testing. The company provides a broad range of products from laboratory equipment to genetic testing tools and clinical diagnostics. Agilent's instruments are widely used in research laboratories, pharmaceutical companies, and government agencies, making it a significant player in the life sciences industry. The company operates in more than 100 countries and has a history of innovation, having developed some of the world's first portable gas chromatographs and UV-Vis spectrophotometers. Agilent's stock is traded on the New York Stock Exchange under the symbol "A."
Pros and Cons of Agilent Technologies Inc. in the next few years
Pros
Cons
Performance of Agilent Technologies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agilent Technologies Inc. | -1.160% | -4.080% | -3.034% | -9.002% | -4.617% | -15.529% | 25.404% |
| Veeva Systems A | 0.130% | -5.271% | -23.417% | -16.282% | -3.593% | 19.846% | -10.302% |
| Thermo Fisher Scientific Inc. | 0.290% | -1.456% | -1.565% | -3.710% | -1.752% | -7.730% | 27.033% |
| Waters Corp. | -2.270% | -0.674% | 3.991% | -8.706% | -4.753% | 5.943% | 70.201% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon initial review, the financials of Agilent Technologies (US Symbol: A) from the Healthcare Equipment & Supplies industry appear to show steady growth and financial stability. The company has managed to increase its net income and total assets over the past few years, suggesting a strong and expanding financial position. This combined with a generally positive industry trend makes Agilent Technologies an interesting player in the healthcare equipment and supplies sector.
Pros
Revenue Growth: From 2020 to 2022, Agilent's total revenue increased from $5.34 billion to $6.85 billion, demonstrating consistent growth. This steady uptick in revenues suggests promising business prospects and an expanding market share in the industry.
Comments
News
Agilent Reports 10% Revenue Jump in Q3
Agilent Technologies (NYSE:A), a global leader in laboratory instruments and scientific solutions for life sciences and diagnostics, released its Q3 fiscal 2025 results on Aug. 27, 2025. The company
Agilent Raises Outlook on Q3 Growth
Agilent Technologies(NYSE:A) reported Q3 FY2025 revenue of $1.74 billion, up 6.1% year-over-year on a core basis, with non-GAAP EPS of $1.37, both exceeding guidance. The company raised its
Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27
Following an announcement earlier this week, Agilent Technologies Inc. (NYSE: A) confirms it will release financial results for the third quarter of fiscal year 2025 after the stock market closes
